Giustina A, Veldhuis JD (1998) Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 19(6):717–797. https://doi.org/10.1210/edrv.19.6.0353
Article CAS PubMed Google Scholar
Giustina A, Mazziotti G, Canalis E (2008) Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev 29(5):535–559. https://doi.org/10.1210/er.2007-0036
Article CAS PubMed PubMed Central Google Scholar
Doga M, Bonadonna S, Gola M, Mazziotti G, Nuzzo M, Giustina A (2005) GH deficiency in the adult and bone. J Endocrinol Invest 28(8 Suppl):18–23
Mazziotti G, Doga M, Frara S, Maffezzoni F, Porcelli T, Cerri L, Maroldi R, Giustina A (2016) Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency. Endocrine.;52(1):103– 10. https://doi.org/10.1007/s12020-015-0738-z. Epub 2015 Oct 3. PMID: 26433736
Giustina A (2023) Acromegaly and bone: an update. Endocrinol Metab (Seoul) 38(6):655–666. https://doi.org/10.3803/EnM.2023.601
Article CAS PubMed Google Scholar
Frara S, Melin Uygur M, di Filippo L, Doga M, Losa M, Santoro S, Mortini P, Giustina A (2022) High prevalence of vertebral fractures Associated with preoperative GH levels in patients with recent diagnosis of Acromegaly. J Clin Endocrinol Metab Jun 16(7):e2843–e2850. https://doi.org/10.1210/clinem/dgac183
Mazziotti G, Bianchi A, Bonadonna S, Nuzzo M, Cimino V, Fusco A, De Marinis L, Giustina A (2006) Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. J Bone Miner Res.;21(4):520-8. https://doi.org/10.1359/jbmr.060112. Epub 2006 Apr 5. PMID: 16598371
Mazziotti G, Maffezzoni F, Frara S, Giustina A, Acromegalic osteopathy (2017) Pituitary.;20(1):63–69. https://doi.org/10.1007/s11102-016-0758-6. PMID: 27709412
Potapov A, Liebich I, Dönitz J, Schwarzer K, Sasse N, Schoeps T, Crass T, Wingender E (2006) EndoNet: an information res ource about endocrine networks. Nucleic Acids Res 34:D540–D545
Article CAS PubMed Google Scholar
Giustina A, Karamouzis I, Patelli I, Mazziotti G (2013) Octreotide for acromegaly treatment: a reappraisal. Expert Opin Pharmacother.;14(17):2433-47. https://doi.org/10.1517/14656566.2013.847090. Epub 2013 Oct 14. PMID: 24124691
Uygur MM, Villanova M, Frara S, Giustina A (2024) Clinical pharmacology of oral Octreotide capsules for the treatment of Acromegaly. touchREV Endocrinol 20(1):37–42. https://doi.org/10.17925/EE.2024.20.1.9. Epub 2024 Jan 22. PMID: 38812667; PMCID: PMC11132652
Article PubMed PubMed Central Google Scholar
Hermann M, Berger P (2001) Hormonal changes in aging men: a therapeutic indication? 540 Exp Gerontol. 36:1075–1082
Ribeiro de Oliveira Longo, Schweizer J, Ribeiro-Oliveira A Jr, Bidlingmaier M (2018) Growth hormone: isoforms, clinical aspects and assays interference. Clin Diabetes Endocrinol 4:18. https://doi.org/10.1186/s40842-018-0068-1
Frank SJ, Minireview (2002) Receptor dimerization in GH and Erythropoietin Action—It takes two to Tango, but how. Endocrinology 143(1):2–10. https://doi.org/10.1210/endo.143.1.8607
Gluckman PD, Butler JH, Elliott TB (1983) The ontogeny of somatotropic binding sites in ovine hepatic membranes. Endocrinology May; 112(5):1607–1612
Article CAS PubMed Google Scholar
Maes M, De Hertogh R, Watrin-Granger P, Ketelslegers JM (1983) Ontogeny of liver somatotropic and lactogenic binding sites in male and female rats. Endocrinol Oct 113(4):1325–1332
Brooks AJ, Wooh JW, Tunny KA, Waters MJ (2008) Growth hormone receptor; mechanism of action. Int J Biochem Cell Biol 40(10):1984–1989 Epub 2007 Jul 25. Review
Article CAS PubMed Google Scholar
Brown RJ, Adams JJ, Pelekanos RA, Wan Y, McKinstry WJ, Palethorpe K, Seeber RM, Monks TA, Eidne KA, Parker MW, Waters MJ (2005) Model for growth hormone receptor activation based on subunit rotation within a receptor dimer. Nat Struct Mol Biol Sep 12(9):814–821
Woelfle J, Chia DJ, Rotwein P (2003) Mechanisms of growth hormone (GH) action. Identification of conserved Stat5 binding sites that mediate GH-induced insulin-like growth factor-I gene activation. J Biol Chem Dec 19(51):51261–51266
Zehorai E, Yao Z, Plotnikov A, Seger R (2010) The subcellular localization of MEK and ERK—a novel nuclear translocation signal (NTS) paves a way to the nucleus. Mol Cell Endocrinol 314:213–220
Article CAS PubMed Google Scholar
Carter-Su C, Schwartz J, Argetsinger LS (2016) Growth hormone signaling pathways. Growth Horm IGF Res 28:11–15. https://doi.org/10.1016/j.ghir.2015.09.002. Epub 2015 Sep 10. PMID: 26421979; PMCID: PMC7644140
Article CAS PubMed Google Scholar
Flores-Morales A, Greenhalgh CJ, Norstedt G, Rico-Bautista E (2006) Negative regulation of growth hormone receptor signaling.Negative regulation of growth hormone receptor signaling. Mol Endocrinol 20(2):241–253. https://doi.org/10.1210/me.2005-0170
Article CAS PubMed Google Scholar
Yasukawa H, Misawa H, Sakamoto H, Masuhara M, Sasaki A, Wakioka T, Ohtsuka S, Imaizumi T, Matsuda T, Ihle JN, Yoshimura A (1999) The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop EMBO J. Mar 1;18(5):1309-20
Hansen JA, Lindberg K, Hilton DJ, Nielsen JH, Billestrup N (1999) Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins. Mol Endocrinol Nov 13(11):1832–1843
Pass C, MacRae VE, Ahmed SF, Farquharson C (2009) Inflammatory cytokines and the GH/IGF-I axis: novel actions on bone growth. Cell BiochemFunct 27:119–127
Zapf J, Waldvogel M, Froesch ER (1975) Binding of nonsuppressible insulinlike activity to human serum. Evidence for a carrier protein. Arch Biochem Biophys Jun; 168(2):638–645
Article CAS PubMed Google Scholar
Schwander JC, Hauri C, Zapf J, Froesch ER (1983) Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status. Endocrinol Jul 113(1):297–305
Mohan S, Kesavan C (2012) Role of insulin-like growth factor-1 in the regulation of signaling. Stem Cells Dayt Ohio 19:378e387. https://doi.org/10.1634/stemcells.19-5-378
Isaksson OG, Jansson JO, Gause IA (1982) Growth hormone stimulates longitudinal bone growth directly. Science 216(4551):1237–1239
Article CAS PubMed Google Scholar
Ohlsson C, Nilsson A, Isaksson O, Lindahl A (1992) Growth hormone induces multiplication of the slowly cycling germinal cells of the rat tibial growth plate. Proc. Natl. Acad. Sci. U. S. A. 89, 9826e9830
Wu S, Yang W, De Luca F (2015) Insulin-like growth factor-independent effects of growth hormone on growth plate chondrogenesis and longitudinal bone growth. Endocrinology 156:2541e2551. https://doi.org/10.1210/en.2014-1983
Dobie R, Ahmed SF, Staines KA, Pass C, Jasim S, MacRae VE, Farquharson C (2015) Increased linear bone growth by GH in the absence of SOCS2 is independent of IGF-1.J Cell Physiol.;230(11):2796– 806. https://doi.org/10.1002/jcp.25006. PMID: 25833299
Chen MM, Yeh JK, Aloia JF (1995) Skeletal alterations in hypophysectomized rats: II. A histomorphometric study on tibial cortical bone. Anat Rec Apr 241(4):513–518
Mohan S, Richman C, Guo R, Amaar Y, Donahue LR, Wergedal J, Baylink DJ (2003) Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms. Endocrinology 144:929e936. https://doi.org/10.1210/en.2002-220948
Sims NA, Clement-Lacroix P, Da Ponte F, Bouali Y, Binart N, Moriggl R, Goffin V, Coschigano K, Gaillard-Kelly M, Kopchick J, Baron R, Kelly PA (2000) Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. J Clin Investig 106:1095e1103. https://doi.org/10.1172/JCI10753
Sjögren K, Bohlooly-Y M, Bohlooly YM, Olsson B, Coschigano K, T€ornell J, Mohan S, Isaksson OG, Baumann G, Kopchick J, Ohlsson C (2000) Disproportional skeletal growth and markedly decreased bone mineral content in growth hormone receptor -/- mice. Biochem Biophys Res Commun 267:603e608. https://doi.org/10.1006/bbrc.1999.1986
Liu Z et al (2019) Mitochondrial function is compromised in cortical bone osteocytes of long- lived growth hormone receptor null mice. J Bone Min Res 34:106–122
Canalis E, PROSPECT - GROWTH FACTOR CONTROL OF BONE MASS (2009) J Cell Biochem 108(4):769–777. https://doi.org/10.1002/jcb.22322
Wu Y, Sun H, Basta-Pljakic J, Cardoso L, Kennedy OD, Jasper H, Domene H, Karabatas L, Guida C, Schaffler MB, Rosen CJ, Yakar S (2013) Serum IGF-1 is insufficient to restore skeletal size in the total absence of the growth hormone receptor. J Bone Min Res off J Am Soc Bone Min Res 28:1575e1586. https://doi.org/10.1002/jbmr.1920
Lim SV, Marenzana M, Hopkinson M, List EO, Kopchick JJ, Pereira M, Javaheri B, Roux JP, Chavassieux P, Korbonits M, Chenu C (2015) Excessive growth hormone expression in male GH transgenic mice adversely alters bone architecture and mechanical strength. Endocrinology 156:1362e1371. https://doi.org/10.1210/en.2014-1572
留言 (0)